El Hospital Universitario de Cruces, ​ anteriormente denominado Hospital de Cruces, ​ está situado en el barrio de Cruces de la ciudad de Baracaldo, España. Es el centro sanitario más grande y concurrido del País Vasco.

During the past decade, Hospital de Cruces conducted 164 clinical trials. In the 10-year time frame, 164 clinical trials started and 47 clinical trials were completed, i.e. on average, 28.7% percent of trials that started reached the finish line to date. In the past 5 years, 88 clinical trials started and 28 clinical trials were completed. i.e. 31.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Cruces" #1 sponsor was "PETHEMA Foundation" with 12 trials, followed by "Pfizer" with 11 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored, "Fundación GECP" with 6 trials sponsored and "Ipsen" with 6 trials sponsored. Other sponsors include 198 different institutions and companies that sponsored additional 146 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Cruces" #1 collaborator was "Hospital de Cruces" with 6 trials as a collaborator, "Instituto de Salud Carlos III" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Spanish Clinical Research Network - SCReN" with 4 trials as a collaborator and "Spanish Network for Research in Infectious Diseases" with 4 trials as a collaborator. Other collaborators include 137 different institutions and companies that were collaborators in the rest 124 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Cruces" are "Arthritis, Rheumatoid" (6 trials), "Coronary Artery Disease" (6 trials), "Lung Cancer" (5 trials), "Multiple Myeloma" (5 trials) and "Rheumatoid Arthritis" (5 trials). Many other conditions were trialed in "Hospital de Cruces" in a lesser frequency.

Most popular intervention types in "Hospital de Cruces" are "Drug" (161 trials), "Device" (26 trials), "Biological" (25 trials), "Other" (17 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Dexamethasone" (8 trials), "Carboplatin" (7 trials), "Cisplatin" (5 trials) and "Cyclophosphamide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Cruces" are 230 trials for "All" genders, 11 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Cruces". 3 are not yet recruiting, 47 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 111 completed trials in Hospital de Cruces, 1 suspended trials, and 32 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Cruces, 6 "Phase 1" clinical trials were conducted, 50 "Phase 2" clinical trials and 99 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 26 trials, and there were also 17 trials that are defined as “Not Applicable".